Personalized antibodies for gastroesophageal adenocarcinoma (PANGEA): Secondary and final primary efficacy analyses.

Daniel V.T. Catenacci,Bryan Peterson,Leah Chase,Samantha Lomnicki,Anthony Serritella,Natalie Reizine,Chih-Yi Liao,Lindsay Alpert,Namrata Setia,John Hart,Uzma D. Siddiqui,Sunil Narula,Murtuza M. Rampurwala,Yuan Ji,Theodore Karrison,Blase N. Polite,Hedy L. Kindler

Personalized antibodies for gastroesophageal adenocarcinoma (PANGEA): Secondary and final primary efficacy analyses.

2020

Daniel V.T. Catenacci
Bryan Peterson
Leah Chase
Samantha Lomnicki
Anthony Serritella
Natalie Reizine
Chih-Yi Liao
Lindsay Alpert
Namrata Setia
John Hart
Uzma D. Siddiqui
Sunil Narula
Murtuza M. Rampurwala
Yuan Ji
Theodore Karrison
Blase N. Polite
Hedy L. Kindler

4561Background: Targeted therapies (tx) have had limited benefit in advanced (aGEA) due to baseline spatial (primary vs metastatic tumor PT/MT) & temporal molecular heterogeneity (BMH/TMH). We prev...

Keywords:

Oncology
Internal medicine
gastroesophageal adenocarcinoma
Pathology
Antibody
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations